This approach is supported by epidemiological associations of AN with type 1 diabetes (Hedman et al., 2018) and its genetic overlap with fasting insulin (Duncan et al., 2017), type 2 diabetes (Watson et al., 2019), and insulin sensitivity (Hübel et al., 2018). Here, INS is linked to type 2 diabetes mellitus.